Open Forum Infectious Diseases (ISSN: 2328-8957; E-ISSN: 2328-8957) is a leading open-access journal published by Oxford University Press, dedicated to advancing the field of infectious diseases. Since its inception in 2014, the journal has provided a platform for researchers to disseminate impactful findings in a rapidly evolving domain, achieving a remarkable Q1 ranking in both the Infectious Diseases and Oncology categories as of 2023. The journal encourages rigorous and innovative research, contributing significantly to global health discussions and informing best practices in clinical settings. As an open-access journal, it ensures that its content is accessible to a wide audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Positioned in the heart of the United States, Open Forum Infectious Diseases serves as a critical resource for the academic community, and its continued commitment to quality and relevance secures its status as an essential publication in the field.

PUBLIC HEALTH REPORTS is a premier journal in the field of public health, published by SAGE PUBLICATIONS INC in the United States. With its ISSN 0033-3549 and E-ISSN 1468-2877, this esteemed publication has been an influential voice in the discipline since its inception in 1945. Recognized for its rigorous scholarship, it currently holds a distinguished Q1 ranking in the 2023 category of Public Health, Environmental and Occupational Health, emphasizing its significance with a Scopus rank of #186 out of 665, placing it in the 72nd percentile. The journal aims to disseminate high-quality research that addresses pressing health issues and promotes evidence-based practices, making it a vital resource for researchers, professionals, and students alike. Although it is not an open-access journal, PUBLIC HEALTH REPORTS continues to offer extensive insights and advancements pertinent to the global public health landscape, thereby fostering a deeper understanding and engagement with critical health determinants. Researchers and health practitioners are encouraged to contribute to this dynamic forum where knowledge and innovation converge.

China CDC Weekly is an esteemed academic journal published by the Chinese Center for Disease Control and Prevention, dedicated to disseminating critical research in the fields of epidemiology, infectious diseases, and public health. Since its inception in 2019, the journal has rapidly established itself as a key resource for scholars, professionals, and students, achieving notable rankings, including Q2 in Epidemiology and Infectious Diseases, and Q1 in Public Health, Environmental, and Occupational Health for 2023. With an emphasis on the latest advancements and data-driven insights, China CDC Weekly offers a platform for researchers to contribute to the vital discourse surrounding health policies, disease control, and public safety in a rapidly evolving global landscape. As an open-access journal, it ensures widespread availability and visibility of research findings, reflecting its commitment to advancing public health knowledge in China and beyond. The conference years from 2019 to 2024 further highlight its responsiveness to emerging health challenges and trends, positioning the journal as a preeminent publication for interdisciplinary collaboration and innovation.

The American Journal of Public Health, published by the American Public Health Association, stands as a cornerstone in the field of public health and epidemiology since its inception in 1949. With its rigorous peer-review process and a robust commitment to advancing knowledge and research practices, this journal holds a prestigious position in the academic community, as reflected in its 2023 Scopus ranking, where it is placed in the top percentile (93rd) within the categories of Public Health and Environmental and Occupational Health. The journal's focus encompasses a broad spectrum of public health topics, making it essential reading for researchers, practitioners, and students dedicated to improving population health. Subscribers can access invaluable insights through its collection of innovative studies and reviews, thereby reinforcing the journal's role in shaping public health policy and practice. By bridging research and real-world application, the American Journal of Public Health remains a vital resource for those engaged in the quest to improve health outcomes across diverse communities.

Genome Medicine is a prestigious, peer-reviewed journal published by BMC, focusing on the rapidly evolving fields of genetics, molecular biology, and molecular medicine. Established in 2009 and boasting an open-access format, it has become a leading platform for disseminating high-quality research findings that advance our understanding of genetic diseases and therapeutic innovations. With an impressive Q1 ranking across multiple relevant categories—in particular, genetics (clinical), molecular biology, and molecular medicine—this journal is recognized for its substantial impact in the academic community, as evidenced by its exceptional placement in Scopus rankings. By providing unrestricted access to groundbreaking studies, Genome Medicine fosters collaboration and knowledge sharing among researchers, clinicians, and educators, thus playing a vital role in the transition from fundamental genetic research to clinical applications. Researchers are encouraged to contribute their findings and insights, further solidifying the journal’s position as a pivotal resource for those dedicated to advancing genomic medicine.

JMIR Public Health and Surveillance is a premier open access journal that has been at the forefront of public health research since its inception in 2015. Published by JMIR PUBLICATIONS, INC in Canada, this journal holds an impressive Q1 ranking in both Health Informatics and Public Health, Environmental and Occupational Health as of 2023. With a commendable Scopus Rank of #18 out of 665 in Public Health and #10 out of 138 in Health Informatics, JMIR Public Health and Surveillance stands out for its rigorous peer-reviewed articles that contribute significantly to the advancement of knowledge in these vital fields. The journal is committed to promoting research that advances the understanding and surveillance of health trends, disease outbreaks, and population health metrics, thus serving as an invaluable resource for researchers, professionals, and students alike. By facilitating open access to high-quality content, it ensures that results of critical public health research are readily available, ultimately helping to inform policy and public health initiatives across the globe.

IJID Regions is a pioneering open access journal published by Elsevier, focusing on the critical fields of epidemiology, infectious diseases, and public health. Established in 2021, the journal aims to provide a platform for disseminating high-quality, innovative research that addresses pressing health issues and informs evidence-based practices in communities around the globe. With its impact factors reflecting a Tier Q2 and Q3 ranking in various medical subcategories on the Scopus platform, IJID Regions is positioned as a valuable resource for researchers, health professionals, and policy-makers striving to enhance public health outcomes. This journal not only champions open access since its inception, promoting the free flow of information, but also welcomes contributions that shed light on contemporary challenges in environmental and occupational health. Its commitment to fostering dialogue and collaboration in the health sciences is paramount, making it an essential read for those engaged in advancing public health knowledge and initiatives.

The Central European Journal of Public Health, ISSN 1210-7778 and E-ISSN 1803-1048, is a vital academic forum published by the NATIONAL INSTITUTE OF PUBLIC HEALTH, Czech Republic. With its comprehensive coverage of contemporary issues in public health and medicine since its inception in 1993, this journal aims to bridge the gap between research and practice, fostering a deeper understanding of health dynamics within Central Europe and beyond. As a Q3 ranked journal in both the fields of Medicine (miscellaneous) and Public Health, Environmental and Occupational Health as per 2023 metrics, it provides an accessible platform for innovative studies, policy analyses, and reviews that contribute to the global discourse on public health challenges. Though primarily based in the Czech Republic, it welcomes contributions from a worldwide audience, enhancing its scope and impact. Researchers, practitioners, and students will find invaluable insights that not only enrich academic scholarship but also inform effective public health interventions.

EPIDEMIOLOGIC REVIEWS, an esteemed publication from Oxford University Press Inc, stands as a beacon in the fields of Epidemiology and Medicine, with a significant focus on synthesizing and analyzing the latest research and developments in these areas since its inception in 1979. This journal, with its ISSN 0193-936X and E-ISSN 1478-6729, is recognized for its high academic rigor, boasting a 2023 Q1 quartile ranking in both Epidemiology and Miscellaneous Medicine, and ranks #25 out of 148 in Scopus's Epidemiology category, placing it in the prestigious 83rd percentile. Although it does not currently offer open access, its subscription options provide comprehensive access to a wealth of epidemiological knowledge, essential for researchers, public health professionals, and students keen on advancing their understanding of health trends and disease patterns. With a commitment to promoting high-quality research and impactful insights, EPIDEMIOLOGIC REVIEWS plays a crucial role in enhancing public health discourse and shaping future epidemiological inquiries.

CLINICAL MICROBIOLOGY AND INFECTION is a leading journal published by Elsevier Science Ltd, dedicated to advancing the field of infectious diseases and clinical microbiology. With its ISSN 1198-743X and E-ISSN 1469-0691, this esteemed journal has maintained its influential presence since 1995, showcasing high-impact research that addresses critical issues in the diagnosis, treatment, and prevention of infections. Ranked in the Q1 quartile for Infectious Diseases, Medicine (miscellaneous), and Microbiology (medical) categories, and boasting impressive Scopus rankings of #12 and #7 respectively, it sits at the forefront of scientific inquiry in these disciplines. Although it is not an Open Access journal, it provides comprehensive access options for institutions and individuals, ensuring the dissemination of vital research findings. As the field of clinical microbiology continues to evolve, CLINICAL MICROBIOLOGY AND INFECTION remains an essential resource for researchers, clinicians, and students aiming to stay informed on the latest developments and breakthroughs in understanding infectious diseases.